The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (Nasdaq: ROSG), an innovative molecular diagnostic company, today announced the execution of ...
@JohnCFierce: Derek Lowe explains in concise terms why BioTime's cell aging work has a long, long way to go. Item | Follow @JohnCFierce > Prometheus Laboratories struck a deal to collaborate with ...
Firm’s newly established business will use purchase to move into gastrointestinal testing. Nestlé’s recently established Nestlé Health Science operation will acquire specialty pharmaceutical and ...
SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...
NEW YORK, Nov 7 (Reuters) - Privately held Prometheus Laboratories Inc said on Wednesday it has agreed to acquire exclusive U.S. rights to GlaxoSmithKline's irritable bowel syndrome drug Lotronex.
Prometheus Laboratories holds patents for how to determine the proper dosage of drugs that treat gastrointestinal and other autoimmune diseases. The problem for the company, defending itself Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results